
The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View (2S)-2-acetamido-N-[(1S)-2-[[(1S)-4-amino-1-[[(1S)-4-amino-1-[[(1S,2R)-1-[[(1S)-2-[[(3S,6S,9S,12S,15S,18S,21R,28Z,33S)-33-[[(1S)-4-amino-1-[[(1S)-3-amino-1-carbamoyl-3-oxo-propyl]carbamoyl]-4-oxo-butyl]carbamoyl]-18-(2-amino-2-oxo-ethyl)-9-(4-guanidinobutyl)-12-(1H-indol-3-ylmethyl)-3,6,15-triisobutyl-21,33-dimethyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotritriacont-28-en-21-yl]amino]-1-benzyl-2-oxo-ethyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]-4-oxo-butyl]carbamoyl]-4-oxo-butyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]pentanediamide's neighborhood in the knowledge graph.

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for (2S)-2-acetamido-N-[(1S)-2-[[(1S)-4-amino-1-[[(1S)-4-amino-1-[[(1S,2R)-1-[[(1S)-2-[[(3S,6S,9S,12S,15S,18S,21R,28Z,33S)-33-[[(1S)-4-amino-1-[[(1S)-3-amino-1-carbamoyl-3-oxo-propyl]carbamoyl]-4-oxo-butyl]carbamoyl]-18-(2-amino-2-oxo-ethyl)-9-(4-guanidinobutyl)-12-(1H-indol-3-ylmethyl)-3,6,15-triisobutyl-21,33-dimethyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotritriacont-28-en-21-yl]amino]-1-benzyl-2-oxo-ethyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]-4-oxo-butyl]carbamoyl]-4-oxo-butyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]pentanediamide.

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with (2S)-2-acetamido-N-[(1S)-2-[[(1S)-4-amino-1-[[(1S)-4-amino-1-[[(1S,2R)-1-[[(1S)-2-[[(3S,6S,9S,12S,15S,18S,21R,28Z,33S)-33-[[(1S)-4-amino-1-[[(1S)-3-amino-1-carbamoyl-3-oxo-propyl]carbamoyl]-4-oxo-butyl]carbamoyl]-18-(2-amino-2-oxo-ethyl)-9-(4-guanidinobutyl)-12-(1H-indol-3-ylmethyl)-3,6,15-triisobutyl-21,33-dimethyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotritriacont-28-en-21-yl]amino]-1-benzyl-2-oxo-ethyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]-4-oxo-butyl]carbamoyl]-4-oxo-butyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]pentanediamide.
(2S)-2-acetamido-N-[(1S)-2-[[(1S)-4-amino-1-[[(1S)-4-amino-1-[[(1S,2R)-1-[[(1S)-2-[[(3S,6S,9S,12S,15S,18S,21R,28Z,33S)-33-[[(1S)-4-amino-1-[[(1S)-3-amino-1-carbamoyl-3-oxo-propyl]carbamoyl]-4-oxo-butyl]carbamoyl]-18-(2-amino-2-oxo-ethyl)-9-(4-guanidinobutyl)-12-(1H-indol-3-ylmethyl)-3,6,15-triisobutyl-21,33-dimethyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotritriacont-28-en-21-yl]amino]-1-benzyl-2-oxo-ethyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]-4-oxo-butyl]carbamoyl]-4-oxo-butyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]pentanediamide bioactivity Protein Mdm4
Knowledge Graph Assertion (Entity type)A Knowledge Graph Assertion from IDG
(2S)-2-acetamido-N-[(1S)-2-[[(1S)-4-amino-1-[[(1S)-4-amino-1-[[(1S,2R)-1-[[(1S)-2-[[(3S,6S,9S,12S,15S,18S,21R,28Z,33S)-33-[[(1S)-4-amino-1-[[(1S)-3-amino-1-carbamoyl-3-oxo-propyl]carbamoyl]-4-oxo-butyl]carbamoyl]-18-(2-amino-2-oxo-ethyl)-9-(4-guanidinobutyl)-12-(1H-indol-3-ylmethyl)-3,6,15-triisobutyl-21,33-dimethyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotritriacont-28-en-21-yl]amino]-1-benzyl-2-oxo-ethyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]-4-oxo-butyl]carbamoyl]-4-oxo-butyl]amino]-1-(hydroxymethyl)-2-oxo-ethyl]pentanediamide bioactivity E3 ubiquitin-protein ligase Mdm2
Knowledge Graph Assertion (Entity type)A Knowledge Graph Assertion from IDG